Open Research Studies

Lakeside Healthcare Research and Innovation Unit:

• GSK COPD PAS – A study looking at safety cardiovascular outcome data for two inhalers used in the management of COPD – GSK is the Trial Sponsor.
• Amgen Vesalius CV Study – A study looking at the efficacy of the drug Evolocumab (Repatha) is at lowering LDL-C in patients at risk of having a cardiovascular event – Amgen is the Trial Sponsor.
• Novavax 2019nCoV-302 – A vaccine study looking at the efficacy of the Novavax Covid-19 vaccine in Adults in preventing serious Covid-19 Illness – Novavax is the Trial Sponso
• Valneva VLA2001-301 – A vaccine study looking at the efficacy of the Valneva Covid-19 vaccine in Adults in preventing serious Covid-19 Illness – Valneva is the Trial Sponsor
• GSK RSV 006 – A vaccine study looking at the efficacy of a RSV (Respiratory Syncytial Virus) vaccine within older adults living in the community in preventing RSV infection – GSK is the Trial Sponsor
• Astrazeneca LOGOS study – An Asthma study looking at the effectiveness of new combined triple therapy inhaler in patients with inadequately controlled Asthma – Astrazeneca is the Trial sponsor
• Boeringher Ingelheim 0022 CKD Study – A study for Chronic Kidney Disease looking at a new therapy to improve Kidney Function – Boeringher Ingelheim is the Trial Sponsor